The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update – Notification of Change of Venue

19 Mar 2020 16:30

RNS Number : 8613G
Maven Income and Growth VCT 3 PLC
19 March 2020
 

MAVEN INCOME AND GROWTH VCT 3 PLC

2020 AGM UPDATE - NOTIFICATION OF CHANGE OF VENUE

Maven Income and Growth VCT 3 PLC (the Company) announced its Annual Financial Results for the year to 30 November 2019 on 10 March 2020, including notice that the Annual General Meeting (AGM) would be held in London on Wednesday, 8 April 2020 at 12.00 noon.

In respect of the evolving Coronavirus (COVID-19) situation, which the Board is monitoring closely, the Directors of the Company consider the well-being of its Shareholders and other AGM attendees as a high priority. Based on the latest available advice, the AGM is expected to proceed on 8 April 2020 as planned, however, the Board has resolved that the venue of the AGM should be moved from London to Glasgow.

Accordingly, the Company's 2020 AGM will be held on Wednesday, 8 April 2020 at 12.00 noon at the offices of Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW.

In further consideration of the current situation, Shareholders should also note that only the formal business set out in the Notice of Annual General Meeting, as included in the Annual Report for the year ended 30 November 2019 published on 10 March 2020, will be considered at the AGM and that there will be no presentation by the Manager. The meeting will be conducted swiftly and the room will be vacated promptly following the close of the meeting. No refreshments will be served.

The Directors are aware that the AGM is a good opportunity for Shareholders to meet the Board and the Manager. However, given the possible health risks arising from travel to, and interaction at, the AGM, Shareholders are actively encouraged to consider whether their attendance at the AGM is necessary. Shareholders wishing to vote on any of the matters of business are urged to do so through completion of a Proxy Form, which can be submitted to the Company. Proxy Forms should be completed and returned in accordance with the instructions thereon and the latest time for the receipt of Proxy Forms is 12.00 noon on Monday, 6 April 2020. Proxy votes can be also be submitted by CREST or on-line using the Registrar's Share Portal Service at www.signalshares.com.

The Board would, therefore, encourage Shareholders not to attend in person and instead submit any questions by e-mail or by letter in advance of the AGM. A summary of responses will be published after the AGM on the Company's website at: www.mavencp.com/migvct3.

Shareholders wishing to submit a question should write to: The Company Secretary, Maven Income and Growth VCT 3 PLC, c/o Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW or email: CoSec@mavencp.com.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

19 March 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAFLFLRVEIALII
Date   Source Headline
26th Jul 201911:25 amRNSHalf-year Report
10th Jul 20195:03 pmRNSTransaction in Own Shares
2nd Jul 20194:20 pmRNSUnaudited Net Asset Value and Interim Dividend
28th May 20193:13 pmRNSTransaction in Own Shares
11th Apr 201910:53 amRNSNet Asset Value(s)
10th Apr 201912:49 pmRNSResult of AGM
1st Mar 20193:01 pmRNSAnnual Financial Report
7th Feb 20194:34 pmRNSTransaction in Own Shares
17th Jan 20193:06 pmRNSNet Asset Value(s)
27th Nov 20182:42 pmRNSTransaction in Own Shares
21st Nov 20184:03 pmRNSNet Asset Value(s)
20th Jul 20184:04 pmRNSHalf-year Report
17th Jul 20184:09 pmRNSTransaction in Own Shares
3rd Jul 20184:30 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:49 pmRNSStatement re DIS
17th May 20184:30 pmRNSDividend Declaration
26th Apr 20189:35 amRNSDirector/PDMR Shareholding
24th Apr 20184:51 pmRNSIssue of Equity
16th Apr 20185:12 pmRNSNet Asset Value(s)
13th Apr 201812:47 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
11th Apr 20181:12 pmRNSResult of AGM
6th Apr 20184:38 pmRNSStatement re Dividend Investment Scheme
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
31st Aug 20175:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.